Utility of the Recombinase Driver CX3CR1::Cre Rat Strain to Evaluate Microglial Contributions to Nicotine Addiction

Smoking remains a leading preventable cause of death, and nicotine is the primary substance responsible for maintaining use of tobacco products. Preclinical rodent models have shown that neuroimmune signaling is dysregulated by nicotine self-administration (SA) within the nucleus accumbens core (NAcore), which is a key region within the mesolimbic brain reward pathway. Microglia are the resident brain immune cell and prior studies have shown that they play an important role in nicotine-related behaviors. However, while there are transgenic mouse lines that allow for specific evaluations of microglia to neurobiology and behavior, there are fewer tools available for rats as a model species thus limiting our ability to evaluate specific contributions of microglia to nicotine SA. Using transgenic rats expressing Cre under the control of the CX3CR1 promoter bred on a Long Evans (LE) background, we show that NAcore microglia can be specifically transduced with Designer Receptors Exclusively Activated by Designer Drugs (DREADDs). We further show that CX3CR1::Cre rats readily self-administer nicotine, and display a characteristic extinction curve that is not different from outbred LE or Cre-negative littermates. Together, these validation studies lay the foundation for future use of this transgenic rat line to evaluate the specific contributions of microglia in the brain to neurobehavioral underpinnings of nicotine addiction.